NorthStar Medical Radioisotopes orders two additional Rhodotron accelerators from IBA

NorthStar Medical Radioisotopes has signed an agreement to purchase two additional Rhodotron TT300 HE electron beam accelerators from IBA for the production of molybdenum-99 at its Beloit, Wisconsin headquarters. This brings the total to five accelerators purchased from IBA.

“NorthStar continues to invest in the future of nuclear medicine using innovative technology to advance environmentally sustainable radioisotope production.”globenewswire.com

• 2 sources
• globenewswire.comNorthStar Medical Radioisotopes and IBA Sign Agreement forIBA SASep 20, 2022
• globenewswire.comNorthStar Medical Radioisotopes and IBA Sign Agreement forIBA SASep 20, 2022

Summarized from public sources; check the original articles before acting on it.